Abstract:Interleukin (IL)-33 is an important member of the IL-1 family that has pleiotropic activities in innate and adaptive immune responses in host defense and disease. It signals through its ligand-binding primary receptor ST2 and IL-1 receptor accessory protein (IL-1RAcP), both of which are members of the IL-1 receptor family. To clarify the interaction of IL-33 with its receptors, we determined the crystal structure of IL-33 in complex with the ectodomain of ST2 at a resolution of 3.27 angstrom. Coupled with structure-based mutagenesis and binding assay, the structural results define the molecular mechanism by which ST2 specifically recognizes IL-33. Structural comparison with other ligand-receptor complexes in the IL-1 family indicates that surface-charge complementarity is critical in determining ligand-binding specificity of IL-1 primary receptors. Combined crystallography and small-angle X-ray-scattering studies reveal that ST2 possesses hinge flexibility between the D3 domain and D1D2 module, whereas IL-1RAcP exhibits a rigid conformation in the unbound state in solution. The molecular flexibility of ST2 provides structural insights into domain-level conformational change of IL-1 primary receptors upon ligand binding, and the rigidity of IL-1RAcP explains its inability to bind ligands directly. The solution architecture of IL-33-ST2-IL-1RAcP complex from small-angle X-ray-scattering analysis resembles IL-1 beta-IL-1RII-IL-1RAcP and IL-1 beta-IL-1RI-IL-1RAcP crystal structures. The collective results confer IL-33 structure-function relationships, supporting and extending a general model for ligand-receptor assembly and activation in the IL-1 family.

IL-33:activation, regulation and function

Immunomodulation of Interleukin-34 and Its Potential Significance As a Disease Biomarker and Therapeutic Target

Immune Function of Interleukin-33 and Its Relation to Human Diseases

Role of IL-33 in Transplant Biology

Biological functions and clinical implications of interleukin-34 in inflammatory diseases

Interleukin-33/serum stimulation-2 pathway: Regulatory mechanisms and emerging implications in immune and inflammatory diseases

Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions

Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.

Advance in the research of relationship between IL-33 and the relevant diseases

Il-33, an Interleukin-1-Like Cytokine That Signals Via the Il-1 Receptor-Related Protein St2 and Induces T Helper Type 2-Associated Cytokines

Interleukin-33 in health and disease

Research Progress on Interleukin-33 and Its Roles in the Central Nervous System

IL-33: a promising therapeutic target for rheumatoid arthritis?

Interleukin-33: Expression, regulation and function in adipose tissues

Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy

Therapeutic Opportunities of Interleukin-33 in the Central Nervous System

IL-33/ST2 Pathway As a Rational Therapeutic Target for CNS Diseases

Structural Insights Into The Interaction Of Il-33 With Its Receptors

IL-33-ST2 Axis in Liver Disease: Progression and Challenge

IL-33 Signaling in Lung Injury.

Emerging Role Of Interleukin-33 In Autoimmune Diseases